Extended adjuvant intermittent letrozole versus continuous letrozole in postmenopausal women with breast cancer (SOLE): a multicentre, open-label, randomised, phase 3 trial
Titel:
Extended adjuvant intermittent letrozole versus continuous letrozole in postmenopausal women with breast cancer (SOLE): a multicentre, open-label, randomised, phase 3 trial
Auteur:
Colleoni, Marco Luo, Weixiu Karlsson, Per Chirgwin, Jacquie Aebi, Stefan Jerusalem, Guy Neven, Patrick Hitre, Erika Graas, Marie-Pascale Simoncini, Edda Kamby, Claus Thompson, Alastair Loibl, Sibylle Gavilá, Joaquín Kuroi, Katsumasa Marth, Christian Müller, Bettina O'Reilly, Seamus Di Lauro, Vincenzo Gombos, Andrea Ruhstaller, Thomas Burstein, Harold Ribi, Karin Bernhard, Jürg Viale, Giuseppe Maibach, Rudolf Rabaglio-Poretti, Manuela Gelber, Richard D Coates, Alan S Di Leo, Angelo Regan, Meredith M Goldhirsch, Aron